About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Appoints Three New Directors
April 13, 2015
click here to read more
Post navigation
Previous Post
Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland
Next Post
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
Related Posts
Phosphagenics Limited Annual General Meeting and Proxy Form
April 15, 2016
Athenex takes Avecho’s Vitamin K injection to FDA pre-IND meeting
January 12, 2023
January 12, 2023
2018 AGM Results
May 28, 2018